Open access · US-GOV via ClinicalTrials.gov Clinical trial

Rationalisation of Polypharmacy by the Geriatric Consultation Team Using the RASP List: a Pilot Study

Authors not listed

Universitaire Ziekenhuizen KU Leuven · 2014

Dysbiosis Human Randomized controlled trial

Abstract

Polypharmacy is a common problem in elderly, leading among others to increased adverse drug events. The aim of this pilot study was to evaluate whether a systematic medication evaluation by a geriatric consultation team using the RASP (Rationalisation of drugs on admission by an adjusted STOPP\*-list in older patients) list could reduce inappropriate prescribing for elderly admitted patients, admitted to non-geriatric departments. (\* = Screening Tool of Older Persons' potentially inappropriate Prescriptions)

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-23 MST

Cite this

APA

Anonymous. (2014). Rationalisation of Polypharmacy by the Geriatric Consultation Team Using the RASP List: a Pilot Study. <em>Universitaire Ziekenhuizen KU Leuven</em>. https://clinicaltrials.gov/study/NCT02165618

Vancouver

Anonymous. Rationalisation of Polypharmacy by the Geriatric Consultation Team Using the RASP List: a Pilot Study. Universitaire Ziekenhuizen KU Leuven. 2014.

BibTeX

@misc{anon2014Ration, title = {Rationalisation of Polypharmacy by the Geriatric Consultation Team Using the RASP List: a Pilot Study}, author = {Anonymous}, journal = {Universitaire Ziekenhuizen KU Leuven}, year = {2014}, }